Lindahl acts as an advisor when Amferia enters into an agreement with Orkla Wound Care
Through the collaboration with Orkla Wound Care, Amferia’s innovative technology will reach the veterinary market through Orkla’s leading brand Snögg Animal Care.
Amferia’s technology is based on an antimicrobial gel that inhibits bacterial growth and can help prevent infections – a priority area in the European veterinary market, particularly in view of the growing risk of antibiotic-resistant infections. Amferia’s technology and materials have been developed through many years’ research in collaboration with Chalmers University of Technology.
Read more about Amferia and the agreement at amferia.com.
Patrik Rindstål was the Lindahl partner in charge.
Do you want to know more? Contact:
Patrik Rindstål
Managing Partner Uppsala | AdvokatCarousel items
-
News articles
4/1/2026
Insights from Oxford: climate transition is business-critical
When leading experts gathered in Oxford for this year's Climate Policy Monitor symposium, one thing was clear: climate is no longer purely a regulatory issue – it is business-critical.
-
Knowledge
3/30/2026
How to deal with bankruptcy during legal proceedings
What happens to ongoing legal proceedings if the opposing party goes bankrupt? We explain the estate's right to take over the claim and the risks involved.
-
Cases and transactions
3/23/2026
Lindahl advises Seafire on the acquisition of Splendor Plant AB
Lindahl has acted as legal adviser to Seafire in connection with the acquisition of all shares in Splendor Plant AB, the Nordic region's leading wholesale plant nursery, and in negotiations regarding an expanded financing agreement with its existi...
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?
